|
Preclinical Studies of Noncharged Oxime Reactivators for Organophosphate Exposure: NONCHARGED OXIME REACTIVATORS
|
journal
|
August 2013 |
|
Definitive Evidence for the Acute Sarin Poisoning Diagnosis in the Tokyo Subway
|
journal
|
May 1997 |
|
Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology
|
journal
|
February 2005 |
|
A Novel Design of Artificial Membrane for Improving the PAMPA Model
|
journal
|
January 2008 |
|
A specific antidote against lethal alkyl phosphate intoxication. II. Antidotal properties
|
journal
|
October 1956 |
|
A specific antidote against lethal alkylphosphate intoxication
|
journal
|
January 1956 |
|
VMD: Visual molecular dynamics
|
journal
|
February 1996 |
|
Analysis of a 10-ns Molecular Dynamics Simulation of Mouse Acetylcholinesterase
|
journal
|
August 2001 |
|
Clinical evaluation of pesticide exposure and poisonings
|
journal
|
April 1997 |
|
The role of excitotoxicity in organophosphorous nerve agents central poisoning
|
journal
|
June 1997 |
|
A Method to Predict Blood-Brain Barrier Permeability of Drug-Like Compounds Using Molecular Dynamics Simulations
|
journal
|
August 2014 |
|
Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123
|
journal
|
September 2009 |
|
Reaction profiles of the interaction between sarin and acetylcholinesterase and the S203C mutant: Model nucleophiles and QM/MM potential energy surfaces
|
journal
|
September 2010 |
|
Butyrylcholinesterase and G116H, G116S, G117H, G117N, E197Q and G117H/E197Q mutants: A molecular dynamics study
|
journal
|
September 2010 |
|
Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents
|
journal
|
November 2016 |
|
Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX
|
journal
|
November 2016 |
|
Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor
|
journal
|
August 2017 |
|
The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs
|
journal
|
November 2017 |
|
Biomedical potentialities of cationic geminis as modulating agents of liposome in drug delivery across biological barriers and cellular uptake
|
journal
|
September 2020 |
|
Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: A modified kinetic approach
|
journal
|
December 2010 |
|
History of chemical and biological warfare agents
|
journal
|
October 2005 |
|
Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase
|
journal
|
July 2006 |
|
Novel substituted phenoxyalkyl pyridinium oximes enhance survival and attenuate seizure-like behavior of rats receiving lethal levels of nerve agent surrogates
|
journal
|
January 2016 |
|
Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques
|
journal
|
September 2018 |
|
The estimation of oxime efficiency is affected by the experimental design of phosphylated acetylcholinesterase reactivation
|
journal
|
September 2018 |
|
Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases
|
journal
|
March 2020 |
|
Pharmacokinetics of Three Oximes in a Guinea Pig Model and Efficacy of Combined Oxime Therapy
|
journal
|
May 2020 |
|
A High-Throughput Method for the Conversion of CO 2 Obtained from Biochemical Samples to Graphite in Septa-Sealed Vials for Quantification of 14 C via Accelerator Mass Spectrometry
|
journal
|
May 2003 |
|
Large-Scale First-Principles Molecular Dynamics Simulations with Electrostatic Embedding: Application to Acetylcholinesterase Catalysis
|
journal
|
November 2015 |
|
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents
|
journal
|
April 2018 |
|
Predicting a Drug’s Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data
|
journal
|
May 2017 |
|
Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity
|
journal
|
May 2017 |
|
Pharmacokinetic Evaluation of Brain Penetrating Morpholine-3-hydroxy-2-pyridine Oxime as an Antidote for Nerve Agent Poisoning
|
journal
|
February 2020 |
|
Toward Fully Automated High Performance Computing Drug Discovery: A Massively Parallel Virtual Screening Pipeline for Docking and Molecular Mechanics/Generalized Born Surface Area Rescoring to Improve Enrichment
|
journal
|
December 2013 |
|
Amidine−Oximes: Reactivators for Organophosphate Exposure
|
journal
|
May 2011 |
|
Imidazole Aldoximes Effective in Assisting Butyrylcholinesterase Catalysis of Organophosphate Detoxification
|
journal
|
February 2014 |
|
Syrian gas attack reinforces need for better anti-sarin drugs
|
journal
|
October 2013 |
|
Drug resistance in brain diseases and the role of drug efflux transporters
|
journal
|
July 2005 |
|
The ‘aromatic patch’ of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors
|
journal
|
October 1998 |
|
Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6
|
journal
|
May 2016 |
|
New Structural Scaffolds for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases
|
journal
|
April 2011 |
|
Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases
|
journal
|
February 2012 |
|
Rational design, synthesis, and evaluation of uncharged, “smart” bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase
|
journal
|
March 2020 |
|
Synthesis and In Vitro and In Vivo Inhibition Potencies of Highly Relevant Nerve Agent Surrogates
|
journal
|
January 2012 |
|
Novel Brain-Penetrating Oxime Acetylcholinesterase Reactivators Attenuate Organophosphate-Induced Neuropathology in the Rat Hippocampus
|
journal
|
March 2019 |
|
Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase
|
journal
|
January 1999 |
|
Novel brain‐penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates
|
journal
|
May 2016 |
|
Evaluation of Microdosing to Assess Pharmacokinetic Linearity in rats Using Liquid Chromatography-Tandem mass Spectrometry
|
journal
|
December 2005 |
|
In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System
|
journal
|
October 2007 |
|
How to defeat a nerve agent
|
journal
|
January 2018 |
|
A Wrench in the Works of Human Acetylcholinesterase: Soman Induced Conformational Changes Revealed by Molecular Dynamics Simulations
|
journal
|
April 2015 |
|
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
|
journal
|
October 2016 |
|
Analysis of Pralidoxime in Serum, Brain and CSF of Rats
|
journal
|
May 2009 |
|
In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley?
|
journal
|
April 2018 |
|
The Experimental Oxime K027—A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime
|
journal
|
May 2019 |